Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Ovarian Cancer 2018 NCI 5R01CA200854-03 Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women DOHERTY, JENNIFER UNIVERSITY OF UTAH UT $557,804
Ovarian Cancer 2018 NIAID 5R01AI109008-06 Origin of the innate immunity suppression caused by nairovirus' protease activity PEGAN, SCOTT UNIVERSITY OF GEORGIA GA $311,305
Ovarian Cancer 2018 NCI 5R01CA043054-31 Nuclear Function of Abl in DNA Damage Response WANG, JEAN UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $387,500
Ovarian Cancer 2018 NCI 5R01CA202919-03 Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer ZHANG, RUGANG WISTAR INSTITUTE PA $434,625
Ovarian Cancer 2018 NCI 5R01CA194498-03 CDK12 in Ovarian Cancer KARNITZ, LARRY MAYO CLINIC ROCHESTER MN $393,922
Ovarian Cancer 2018 NCI 5R01CA194064-04 Combination Therapy of OvCA with Oligonucleotides and Photodynamic Therapy MING, XIN WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $283,650
Ovarian Cancer 2018 NCI 5R01CA136494-10 Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle MUKHERJEE, PRIYABRATA UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $304,695
Ovarian Cancer 2018 NCI 5R01CA202846-03 Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles YANG, LILY EMORY UNIVERSITY GA $411,268
Ovarian Cancer 2018 NIMHD 5R01MD009697-03 Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival BRISTOW, ROBERT UNIVERSITY OF CALIFORNIA-IRVINE CA $386,250
Ovarian Cancer 2018 NCI 5R01CA196631-03 A network platform to connect drug response and prognosis phenotypes for cancers LI, HU MAYO CLINIC ROCHESTER MN $395,911
Ovarian Cancer 2018 NCI 5R01CA203348-03 Blocking NK cell shedding of CD16a to increase cancer cell killing WALCHECK, BRUCE UNIVERSITY OF MINNESOTA MN $447,909
Ovarian Cancer 2018 NCI 5R01CA211016-02 Immune Impact on Cancer Chemoresistance ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $611,871
Ovarian Cancer 2018 NCI 5R01CA186700-04 Study of biomarkers in ovarian cancer: modulation by activity & diet intervention THOMSON, CYNTHIA UNIVERSITY OF ARIZONA AZ $687,633
Ovarian Cancer 2018 NCI 5R01CA136512-08 BRCA1 Function in Post-Damage Nuclear Foci LIVINGSTON, DAVID DANA-FARBER CANCER INST MA $515,452
Ovarian Cancer 2018 NCI 5R01CA184088-04 Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy KABANOV, ALEXANDER UNIV OF NORTH CAROLINA CHAPEL HILL NC $344,549
Ovarian Cancer 2018 NIBIB 5R01EB019458-04 Pre-clinical quantitation of ovarian cancer tumor burden using Magnetic Particle Imaging and non-dilutive cell labeling CONOLLY, STEVEN UNIVERSITY OF CALIFORNIA BERKELEY CA $462,841
Ovarian Cancer 2018 NCI 5R01CA119171-11 Nutrition and Physical Activity Assessment Study (NPAAS) NEUHOUSER, MARIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $791,418
Ovarian Cancer 2018 NCI 5R01CA172743-06 Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients SUTPHEN, REBECCA UNIVERSITY OF SOUTH FLORIDA FL $122,930
Ovarian Cancer 2018 NCI 5R01CA190498-04 gp130 as a novel therapeutic target in ovarian cancer NEAMATI, NOURI UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $376,320
Ovarian Cancer 2018 NCI 5R01CA211175-02 Averting recurrent and resistant ovarian tumors WANG, QIEN OHIO STATE UNIVERSITY OH $451,109
Ovarian Cancer 2018 NCI 5R01CA211625-02 Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors KINNEY, ANITA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $608,440
Ovarian Cancer 2018 NCI 5R01CA193249-03 Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance LUTGENDORF, SUSAN UNIVERSITY OF IOWA IA $603,615
Ovarian Cancer 2018 NCI 5R00CA194318-04 Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer BITLER, BENJAMIN UNIVERSITY OF COLORADO DENVER CO $249,001
Ovarian Cancer 2018 NCI 5R01CA211707-02 Functional Effects of Ovarian Cancer Risk Variants GAYTHER, SIMON CEDARS-SINAI MEDICAL CENTER CA $622,079
Ovarian Cancer 2018 NCI 5P30CA015704-43 5446 Research Program: Women's Cancer PORTER, PEGGY FRED HUTCHINSON CANCER RESEARCH CENTER WA $69,359
Ovarian Cancer 2018 NIGMS 5R01GM113940-05 NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers YOU, YOUNGJAE UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $303,400
Ovarian Cancer 2018 NCI 5R01CA190423-04 Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $372,824
Ovarian Cancer 2018 NCI 5R01CA182832-05 An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer MATEI, DANIELA NORTHWESTERN UNIVERSITY AT CHICAGO IL $323,695
Ovarian Cancer 2018 NCI 5R00CA179137-05 Understanding the origin,initiation,and progression of high-grade serous ovarian cancer KIM, JAEYEON INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $236,746
Ovarian Cancer 2018 NCI 5R00CA194309-04 Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer AIRD, KATHERINE PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $210,465
Ovarian Cancer 2018 NCI 1R01CA211574-01A1 Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers SCHILDKRAUT, JOELLEN UNIVERSITY OF VIRGINIA VA $703,749
Ovarian Cancer 2018 NIBIB 5F32EB023101-02 Sequence- and Stereocontrolled Triazolium-containing Precise Polymers for siRNA Complexation and Delivery GOLDER, MATTHEW MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $59,038
Ovarian Cancer 2018 NCI 5P30CA044579-27 5844 Women's Oncology Program - WON SHUPNIK, MARGARET UNIVERSITY OF VIRGINIA VA $55,469
Ovarian Cancer 2018 NCI 1R01CA222251-01 Identification of USP13 as a therapeutic target for ovarian cancer LU, XIONGBIN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $379,129
Ovarian Cancer 2018 NCI 5F30CA213737-02 A Systems Biology Approach to Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer MCGEHEE, CORDELIA MAYO CLINIC ROCHESTER MN $44,724
Ovarian Cancer 2018 NCI 1K08CA222385-01 The role of fallopian tube microbiome in ovarian carcinogenesis YU, BO UNIVERSITY OF WASHINGTON WA $167,724
Ovarian Cancer 2018 NCI 5R00CA175292-05 Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms RIZVI, IMRAN MASSACHUSETTS GENERAL HOSPITAL MA $238,772
Ovarian Cancer 2018 NCI 5R01CA197780-03 Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer DIFEO, ANALISA CASE WESTERN RESERVE UNIVERSITY OH $363,581
Ovarian Cancer 2018 NCI 5R01CA200231-04 PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM TAINER, JOHN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $345,984
Ovarian Cancer 2018 NCI 1R21CA216652-01A1 Genetically Modified Natural Killer Cells for Cancer Immunotherapy MORIARITY, BRANDEN UNIVERSITY OF MINNESOTA MN $167,476
Ovarian Cancer 2018 NCI 1R15CA213103-01A1 Improving tumor specificity and overcoming drug resistance of proteasome inhibitors by a dual-targeted drug delivery system ZHU, LIN TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $443,794
Ovarian Cancer 2018 NCI 5R01CA204119-03 Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI GENKINGER, JEANINE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $415,462
Ovarian Cancer 2018 NCI 1R21CA216796-01A1 Clinical Evaluation of an Implantable Lab-in-a-patient microdevice that measures in-situ response to therapies in advanced ovarian cancer JONAS, OLIVER BRIGHAM AND WOMEN'S HOSPITAL MA $183,736
Ovarian Cancer 2018 NCI 5F30CA206398-03 Novel PD-L1 signals regulating anti-tumor immunity and immunotherapy responses CLARK, CURTIS UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $40,028
Ovarian Cancer 2018 NCI 2R01CA109545-10A1 Receptor Cross-Talk in Early Metastatic Dissemination STACK, MARY UNIVERSITY OF NOTRE DAME IN $330,244
Ovarian Cancer 2018 NCI 5U10CA180860-05 Integrated Translational Genoproteomics Center at Washington University MUTCH, DAVID WASHINGTON UNIVERSITY MO $451,509
Ovarian Cancer 2018 NCI 1R03CA223623-01 The role of CREB3L1 in synergy between oncolytic vaccinia virus and doxorubicin KOZBOR, DANUTA ROSWELL PARK CANCER INSTITUTE CORP NY $85,900
Ovarian Cancer 2018 NCI 5R35CA197605-03 Mucins and immune cell interactions in ovarian cancer pathogenesis & progression CRAMER, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $966,086
Ovarian Cancer 2018 NCI 5R01CA211648-02 Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer ADLI, MAZHAR UNIVERSITY OF VIRGINIA VA $432,788
Ovarian Cancer 2018 NCCIH 5R01AT008824-03 Botanical derived progestins and their impact on women's health BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $359,775
Ovarian Cancer 2018 NCI 5R01CA181543-05 Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells BRUGGE, JOAN HARVARD MEDICAL SCHOOL MA $394,740
Ovarian Cancer 2018 NCI 1R33CA214310-01A1 Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers INCE, TAN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $382,215
Ovarian Cancer 2018 NCI 1R01CA214606-01A1 Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer RODRIGUEZ, GUSTAVO NORTHSHORE UNIVERSITY HEALTHSYSTEM IL $370,707
Ovarian Cancer 2018 NCI 5R01CA190176-04 Effector T Cell Trafficking in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $513,972
Ovarian Cancer 2018 NCI 5R01CA207407-02 Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers STEPHAN, MATTHIAS FRED HUTCHINSON CANCER RESEARCH CENTER WA $371,925
Ovarian Cancer 2018 NCI 5R01CA207260-02 Exploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortium SCHILDKRAUT, JOELLEN UNIVERSITY OF VIRGINIA VA $605,285
Ovarian Cancer 2018 NCI 5R01CA215483-02 Experimental Therapeutics by targeting Spleen Tyrosine Kinase SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $374,971
Ovarian Cancer 2018 NCI 5R01CA200507-02 Optimizing Delivery of Oncolytic Measles Virus Strains with Cell Carriers GALANIS, EVANTHIA MAYO CLINIC ROCHESTER MN $592,664
Ovarian Cancer 2018 NIGMS 1R01GM123018-01A1 Mechanisms of heterochromatin replication SMOLKA, MARCUS CORNELL UNIVERSITY NY $301,056
Ovarian Cancer 2018 NIBIB 5R21EB024101-02 Microfluidic Integrative Circulating miRNA Profiling for Cancer Diagnosis ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE KS $179,959
Ovarian Cancer 2018 NCI 1R01CA214911-01A1 Ovarian Cancer Epigenetics, Immunity and Therapy ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $621,601
Ovarian Cancer 2018 NCI 1R37CA215436-01A1 A novel more effective genotoxic therapy for ovarian cancer SIMPKINS, FIONA UNIVERSITY OF PENNSYLVANIA PA $368,288
Ovarian Cancer 2018 NCI 5U01CA152637-08 Breast, Colorectal, and Ovary Cancer Clinical Validation Center LI, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $1,085,901
Ovarian Cancer 2018 NCI 5R01CA142698-09 Molecular mechanism and relevance of microRNAs in DSB repair pathway choice CHOWDHURY, DIPANJAN DANA-FARBER CANCER INST MA $409,002
Ovarian Cancer 2018 NCI 5R01CA175318-04 A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer HATEFI, ARASH RUTGERS, THE STATE UNIV OF N.J. NJ $354,563
Ovarian Cancer 2018 NCI 5R01CA197784-03 Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients PASICK, RENA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $740,001
Ovarian Cancer 2018 NCI 2U01CA176726-06 Life Course Cancer Epidemiology Cohort in Women WILLETT, WALTER HARVARD SCHOOL OF PUBLIC HEALTH MA $2,423,825
Ovarian Cancer 2018 NCI 5K22CA193860-03 PCOS, Type II diabetes and ovarian cancer risk HARRIS, HOLLY FRED HUTCHINSON CANCER RESEARCH CENTER WA $184,615
Ovarian Cancer 2018 NCI 5R01CA138835-09 The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair GREENBERG, ROGER UNIVERSITY OF PENNSYLVANIA PA $317,509
Ovarian Cancer 2018 NCI 5R01CA214043-02 Macrophage-based ovarian cancer immunotherapy YULL, FIONA VANDERBILT UNIVERSITY TN $358,683
Ovarian Cancer 2018 NCI 1K08CA215312-01A1 A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes MAXWELL, KARA UNIVERSITY OF PENNSYLVANIA PA $173,969
Ovarian Cancer 2018 NCI 5R01CA095175-14 Analysis of BRCA1 Recombination Functions SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER MA $328,700
Ovarian Cancer 2018 NCI 5R01CA203971-03 Deubiquitinases in regulation of BRCA1 pathway YUAN, JIAN MAYO CLINIC ROCHESTER MN $363,713
Ovarian Cancer 2018 NCI 5R01CA208244-02 Investigating 53BP1 'dephosphorylation' as a critical determinant of PARP CHOWDHURY, DIPANJAN DANA-FARBER CANCER INST MA $385,413
Ovarian Cancer 2018 NCI 5R03CA208573-02 Metformin Supplementation for Ovarian Cancer Prevention: A Prospective Preclinical Study RAMACHANDRAN, RAMESH PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $78,600
Ovarian Cancer 2018 NCI 5R21CA204036-02 In vivo anti-PD1 gene therapy LIEBER, ANDRE UNIVERSITY OF WASHINGTON WA $168,970
Ovarian Cancer 2018 NCI 5R01CA214567-02 Isozyme-selective ALDH Inhibitors for Sensitizing Ovarian Cancer Stem-like Cells to Chemotherapy LARSEN, SCOTT UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $603,477
Ovarian Cancer 2018 NCI 5R01CA183040-05 Ovarian cancer gene therapy using HPV pseudovirion WU, TZYY-CHOOU JOHNS HOPKINS UNIVERSITY MD $336,150
Ovarian Cancer 2018 NCI 5R01CA214545-02 Targeting Kinesin Family Member 15 for the Treatment of Cancer GODWIN, ANDREW UNIVERSITY OF KANSAS MEDICAL CENTER KS $623,043
Ovarian Cancer 2018 NCI 5R01CA215797-02 Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors DANNENBERG, ANDREW WEILL MEDICAL COLL OF CORNELL UNIV NY $555,691
Ovarian Cancer 2018 NCI 5U01CA200462-03 MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $910,580
Ovarian Cancer 2018 NCI 5U01CA152990-08 Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery SKATES, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $1,323,251
Ovarian Cancer 2018 NCI 5U01CA200469-03 Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer ZHANG, ZHEN JOHNS HOPKINS UNIVERSITY MD $441,524
Ovarian Cancer 2018 NHLBI 5R01HL132251-02 The Roles and Regulation of BRCA1 in Hematopoiesis ROSS, THEODORA UT SOUTHWESTERN MEDICAL CENTER TX $405,000
Ovarian Cancer 2018 NCI 1R43CA224602-01A1 Reversing/Blocking T cell suppression by extracellular vesicles as cancer therapy BHATTA, MAULASRI IMMUNE MODULATORY THERAPIES, LLC NY $280,928
Ovarian Cancer 2018 NICHD 5R01HD083930-03 Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation ZELINSKI, MARY OREGON HEALTH & SCIENCE UNIVERSITY OR $588,107
Ovarian Cancer 2018 NCI 1F30CA224986-01 Role of PAX8 in High Grade Serous Ovarian Cancer RODGERS, LAURA UNIVERSITY OF ILLINOIS AT CHICAGO IL $49,524
Ovarian Cancer 2018 NCI 5R01CA216234-02 Role of microbiota in therapy to ovarian cancer RANDALL, TROY UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $426,139
Ovarian Cancer 2018 NCI 1R01CA218664-01A1 Deep Ovarian Cancer Metabolomics FERNANDEZ, FACUNDO GEORGIA INSTITUTE OF TECHNOLOGY GA $410,432
Ovarian Cancer 2018 NCI 5F30CA217079-02 FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics YOUNG, ALEXANDRIA UNIVERSITY OF ILLINOIS AT CHICAGO IL $44,524
Ovarian Cancer 2018 NCI 5R01CA211932-02 Molecularly-Targeted Ultrasound in Ovarian Cancer LUTZ, AMELIE STANFORD UNIVERSITY CA $484,088
Ovarian Cancer 2018 NCI 5R01CA209818-02 Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer MINKO, TAMARA RUTGERS, THE STATE UNIV OF N.J. NJ $463,244
Ovarian Cancer 2018 NCI 5R01CA215587-02 Multi-Modal Imaging of Psychostimulant Effects on Executive Function Post-RRSO EPPERSON, C. NEILL UNIVERSITY OF PENNSYLVANIA PA $541,065
Ovarian Cancer 2018 NIGMS 5R35GM118175-03 Homologous recombination mechanisms in mammalian cells JASIN, MARIA SLOAN-KETTERING INST CAN RESEARCH NY $531,434
Ovarian Cancer 2018 NCI 5U01CA213759-02 Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling LOPEZ-BERESTEIN, GABRIEL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $500,198
Ovarian Cancer 2018 NCI 5R01CA132755-11 Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis YU, XIAOCHUN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $382,500
Ovarian Cancer 2018 NCI 5R01CA115483-14 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA AT DAVIS CA $345,281
Ovarian Cancer 2018 NCI 5R01CA196619-03 Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm CHO, KATHLEEN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $489,122
Ovarian Cancer 2018 NCI 5R01CA197976-04 The Hippo/Yap Signaling Pathway In Ovarian High Grade Serous Carcinoma WANG, CHENG MASSACHUSETTS GENERAL HOSPITAL MA $376,067
Ovarian Cancer 2018 NCI 5R01CA182413-04 Origins of Ovarian Carcinoma NIKITIN, ALEXANDER CORNELL UNIVERSITY NY $421,580
Ovarian Cancer 2018 NCI 5R01CA206561-03 Quantitative assessment of the role of collagen alterations in ovarian cancer CAMPAGNOLA, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $389,549
Ovarian Cancer 2018 NIGMS 5R35GM118026-03 Mechanisms of Genome Integrity GREENE, ERIC COLUMBIA UNIVERSITY HEALTH SCIENCES NY $530,719
Ovarian Cancer 2018 NIGMS 5P20GM103625-07 5373 Dysbiosis-induced impairment of tumoral leukocyte extravasation DINGS, RUUD UNIV OF ARKANSAS FOR MED SCIS AR $283,100
Ovarian Cancer 2018 NCI 5K22CA207602-02 The role of short-form Ron (sfRon) kinase in the pathogenesis of high-grade serous ovarian cancer BIENIASZ, MAGDALENA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $159,705
Ovarian Cancer 2018 NCI 5R01CA176166-05 Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer CANTOR, SHARON UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $347,563
Ovarian Cancer 2018 NCI 5R01CA188900-04 Novel immunological biomarkers ovarian cancer prognosis SEGAL, BRAHM ROSWELL PARK CANCER INSTITUTE CORP NY $632,858
Ovarian Cancer 2018 NCI 5R01CA193965-03 Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening TERRY, KATHRYN BRIGHAM AND WOMEN'S HOSPITAL MA $371,704
Ovarian Cancer 2018 NCI 5R21CA191243-03 Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid SULCHEK, TODD GEORGIA INSTITUTE OF TECHNOLOGY GA $109,753
Ovarian Cancer 2018 NCI 5K07CA201013-03 Health Services Career Development: Improving Medical Decisions in Ovarian Cancer MEYER, LARISSA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $170,626
Ovarian Cancer 2018 NCI 5R01CA204019-03 Multiplexed analysis of exosomes in cancer nano therapy WEISSLEDER, RALPH MASSACHUSETTS GENERAL HOSPITAL MA $389,031
Ovarian Cancer 2018 NCI 5R01CA176078-05 Dissecting the role of STAT3 and targeting ovarian cancer KARUPPAIYAH, SELVENDIRAN OHIO STATE UNIVERSITY OH $320,524
Ovarian Cancer 2018 NCI 5R01CA195670-04 The Tumor Suppressor Role of SMARCA4 in SCCOHT WEISSMAN, BERNARD UNIV OF NORTH CAROLINA CHAPEL HILL NC $714,783
Ovarian Cancer 2018 NCI 2P30CA046592-29 7945 Cancer Epidemiology & Prevention (CEP) Program PEARCE, CELESTE UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $40,120
Ovarian Cancer 2018 NIBIB 5R01EB022033-03 Engineering an immuno-isolating hydrogel for restoring ovarian endocrine function SHIKANOV, ARIELLA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $374,475
Ovarian Cancer 2018 NCI 1R01CA225680-01 Role of CPT1A as a lysine succinyltransferase in tumorigenesis HITOSUGI, TARO MAYO CLINIC ROCHESTER MN $363,713
Ovarian Cancer 2018 NIGMS 2SC1GM127278-05A1 Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugs CONTEL, MARIA BROOKLYN COLLEGE NY $392,500
Ovarian Cancer 2018 NIGMS 5R01GM097272-07 Cellular responses to DNA replication stress SMOLKA, MARCUS CORNELL UNIVERSITY NY $333,931
Ovarian Cancer 2018 NCI 5U01CA214114-02 Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit PAULOVICH, AMANDA FRED HUTCHINSON CANCER RESEARCH CENTER WA $1,441,604
Ovarian Cancer 2018 NCI 1R01CA225662-01 The contribution of RAD51C and RAD51D to breast and ovarian cancer COUCH, FERGUS MAYO CLINIC ROCHESTER MN $511,059
Ovarian Cancer 2018 NIGMS 5R35GM119512-03 Connecting BRCA1 functions with DNA crosslink sensitivity LONG, DAVID MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $373,750
Ovarian Cancer 2018 NCI 1R01CA225697-01 Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: The Georgia-California GeneLINK Initiative KURIAN, ALLISON STANFORD UNIVERSITY CA $480,620
Ovarian Cancer 2018 NCI 5R01CA193578-04 Tunable Microchip Sorting of BRCA1 Nuclear Assemblies KELLY, DEBORAH VIRGINIA POLYTECHNIC INST AND ST UNIV VA $363,836
Ovarian Cancer 2018 NCI 1R01CA227622-01 Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer NAGRATH, DEEPAK UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $485,829
Ovarian Cancer 2018 NCI 1R01CA227433-01 TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE GRINSTAFF, MARK BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) MA $608,862
Ovarian Cancer 2018 NCI 1U01CA226055-01 Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers ABBOTT, KAREN UNIV OF ARKANSAS FOR MED SCIS AR $768,101
Ovarian Cancer 2018 NCI 5R01CA211916-02 Nicotinamide N-Methyltransferase (NNMT) as a master regulator of cancer stroma LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $371,806
Ovarian Cancer 2018 NCI 5R01CA207768-02 Role of MAST1 kinase in cisplatin resistant cancers KANG, SUMIN EMORY UNIVERSITY GA $356,850
Ovarian Cancer 2018 NCI 5R21CA220078-02 The Role of Splice Quantitative Traits in Ovarian Cancer Pathogenesis LAWRENSON, KATE CEDARS-SINAI MEDICAL CENTER CA $181,178
Ovarian Cancer 2018 NCI 1R21CA226302-01 Targeting the IL-6 - SPINK1 regulatory axis in ovarian clear cell carcinoma RADISKY, EVETTE MAYO CLINIC JACKSONVILLE FL $183,322
Ovarian Cancer 2018 NCI 1R21CA227259-01 Role of human endogenous retroviruses in tumor immunity of ovarian carcinoma CHIAPPINELLI, KATHERINE GEORGE WASHINGTON UNIVERSITY DC $191,044
Ovarian Cancer 2018 NCI 1R21CA218973-01A1 Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer BIRRER, MICHAEL UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $203,042
Ovarian Cancer 2018 NCI 5R01CA155025-08 The role of a BRCA1 associated complex in DNA damage response and tumor suppression WANG, BIN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $380,000
Ovarian Cancer 2018 NCI 5R01CA102310-15 Role of FAK in Tumorigenesis SCHLAEPFER, DAVID UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $331,313
Ovarian Cancer 2018 NCI 5R01CA131582-09 Identification of Ovarian Cancer Plasma Biomarkers SPEICHER, DAVID WISTAR INSTITUTE PA $452,569
Ovarian Cancer 2018 NCI 5K12CA090628-18 Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic JATOI, AMINAH MAYO CLINIC ROCHESTER MN $746,756
Ovarian Cancer 2018 NCI 5R01CA188571-04 DYRK1A signaling in control of cell growth, proliferation and DNA damage repair LITOVCHICK, LARISA VIRGINIA COMMONWEALTH UNIVERSITY VA $341,494
Ovarian Cancer 2018 NCI 5K12CA076930-18 Career Development in Pediatric and Medical Oncology BERNSTEIN, IRWIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $672,442
Ovarian Cancer 2018 NCI 5R01CA193136-04 MDSCs in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $498,257
Ovarian Cancer 2018 NCI 5R01CA197359-04 Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy BERLIN, JACOB BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $388,875
Ovarian Cancer 2018 NCI 5R01CA207034-03 Mechanism of evasion by ovarian cancers from anti-VEGF therapy NAORA, HONAMI UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Ovarian Cancer 2018 NCI 5R01CA196200-04 Ovarian Cancer Chemoprevention BENBROOK, DORIS UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $465,809
Ovarian Cancer 2018 NCI 5R01CA184717-05 The Regulation of Cisplatin resistance in ovarian cancer ZHU, WENGE GEORGE WASHINGTON UNIVERSITY DC $328,888
Ovarian Cancer 2018 NCI 5R01CA188251-05 Molecular Insights into the Fanconi Anemia Tumor Suppressor Signaling Pathway FEI, PEIWEN UNIVERSITY OF HAWAII AT MANOA HI $319,550
Ovarian Cancer 2018 NCI 2R01CA124515-13 Regulatory Dendritic Cells in Cancer CONEJO-GARCIA, JOSE H. LEE MOFFITT CANCER CTR & RES INST FL $367,650
Ovarian Cancer 2018 NCI 5R01CA199004-04 Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer MOR, GIL YALE UNIVERSITY CT $511,177
Ovarian Cancer 2018 NCI 1R01CA219495-01A1 Inhibin function in tumor angiogenesis KARTHIKEYAN, MYTHREYE UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $16,102
Ovarian Cancer 2018 NIGMS 1R01CA219495-01A1 Inhibin function in tumor angiogenesis KARTHIKEYAN, MYTHREYE UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $320,000
Ovarian Cancer 2018 NCI 1R01CA219829-01A1 Exosomes and platinum-induced peripheral neuropathy ZHANG, ZHENG GANG HENRY FORD HEALTH SYSTEM MI $358,545
Ovarian Cancer 2018 NCI 5R01CA196988-02 Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer ANTALIS, TONI UNIVERSITY OF MARYLAND BALTIMORE MD $353,419
Ovarian Cancer 2018 NIBIB 5R01EB020605-03 Advanced Salpingoscope for Minimally-Invasive Imaging of the Fallopian Tubes BARTON, JENNIFER UNIVERSITY OF ARIZONA AZ $299,559
Ovarian Cancer 2018 NCI 1R01CA217931-01A1 Pre-metastatic Omental Niche Formation in Ovarian Cancer NAORA, HONAMI UNIVERSITY OF TX MD ANDERSON CAN CTR TX $383,129
Ovarian Cancer 2018 NCI 5R01CA163377-07 Targeting EZH2 in CARM1-expressing epithelial ovarian cancer ZHANG, RUGANG WISTAR INSTITUTE PA $406,125
Ovarian Cancer 2018 NCI 5F30CA203095-03 Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer PRIEDIGKEIT, NOLAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $49,524
Ovarian Cancer 2018 NCI 5P30CA006973-55 8090 Breast and Ovarian Cancer Program - 08 STEARNS, VERED JOHNS HOPKINS UNIVERSITY MD $36,914
Ovarian Cancer 2018 NCI 1R01CA216436-01A1 Nanoscale Coordination Polymers Co-deliver Chemotherapeutics and siRNAs for Efficacious Treatment of Resistant Ovarian Cancer LIN, WENBIN UNIVERSITY OF CHICAGO IL $439,699
Ovarian Cancer 2018 NHLBI 5R34HL135226-02 Thromboprophylaxis with rosuvastatin following surgery for ovarian cancer ZWICKER, JEFFREY BETH ISRAEL DEACONESS MEDICAL CENTER MA $220,500
Ovarian Cancer 2018 NCI 5R01CA135354-08 ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $380,000
Ovarian Cancer 2018 NCI 5R01CA213119-02 Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer KASAHARA, NORIYUKI UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $504,040
Ovarian Cancer 2018 NCI 1R01CA219187-01A1 Hedgehog/Gli1-targeted therapies to overcome ovarian cancer chemoresistance and disease recurrence PALLE, KOMARAIAH UNIVERSITY OF SOUTH ALABAMA AL $350,750
Ovarian Cancer 2018 NCI 5R01CA211975-02 Cell Cycle Blockade and Therapeutic Sensitization SIDDIK, ZAHID UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Ovarian Cancer 2018 NCI 5R01CA208753-03 Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies ORSULIC, SANDRA CEDARS-SINAI MEDICAL CENTER CA $400,313
Ovarian Cancer 2018 NCI 5P50CA159981-06 RPCI-UPCI Ovarian Cancer SPORE ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $1,750,206
Ovarian Cancer 2018 NCI 1R21CA215662-01A1 The effects of moderate exercise on distress, quality of life, and biomarkers of angiogenesis and chronic stress in ovarian cancer survivors PENNINGTON, KATHRYN UNIVERSITY OF WASHINGTON WA $236,632
Ovarian Cancer 2018 NCI 5R01CA160331-07 Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer ZHANG, RUGANG WISTAR INSTITUTE PA $423,225
Ovarian Cancer 2018 NCI 5R01CA187209-05 Functional analysis of BRCA1 in DNA damage response and tumor suppression YU, XIAOCHUN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $352,750
Ovarian Cancer 2018 NCI 5R01CA207497-03 Provectors for treatment of ovarian cancer SUH, JUNGHAE RICE UNIVERSITY TX $352,623
Ovarian Cancer 2018 NCI 5K01CA218305-02 The Impact of Maternal Obesity on the Reprogramming of the Metastatic Microenvironment HILLIARD, TYVETTE UNIVERSITY OF NOTRE DAME IN $103,375
Ovarian Cancer 2018 NCI 5R50CA211280-03 Discovery and Characterization of Mutations in Breast and Ovarian Cancers ADAMSON, AARON BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $215,047
Ovarian Cancer 2018 NCI 5R35CA197458-04 GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER KING, MARY-CLAIRE UNIVERSITY OF WASHINGTON WA $899,750
Ovarian Cancer 2018 NIGMS 5R01GM059078-19 Molecular Probes for Biomembrane Recognition SMITH, BRADLEY UNIVERSITY OF NOTRE DAME IN $376,927
Ovarian Cancer 2018 NINR 5R21NR016905-02 Testing an Intelligent Tutoring System Intervention to Enhance Genetic Risk Assessment in Underserved Blacks and Latinas at Risk of Hereditary Breast Cancer HURTADO DE MENDOZA CASAUS, ALEJANDRA GEORGETOWN UNIVERSITY DC $235,125
Ovarian Cancer 2018 NCI 5R01CA210370-03 Early detection of ovarian cancer by serum marker and targeted ultrasound imaging BARUA, ANIMESH RUSH UNIVERSITY MEDICAL CENTER IL $356,233
Ovarian Cancer 2018 NCI 5P30CA036727-32 5725 Molecular and Biochemical Etiology (MBE) BAND, HAMID UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $64,409
Ovarian Cancer 2018 NCI 5U24CA209999-03 Monitoring tumor subclonal heterogeneity over time and space MARTH, GABOR UNIVERSITY OF UTAH UT $754,072
Ovarian Cancer 2018 NCI 5R03CA212127-02 The role of X chromosome inactivation in ovarian cancer WINHAM, STACEY MAYO CLINIC ROCHESTER MN $79,500
Ovarian Cancer 2018 NCI 5R25CA217723-02 Programa de ARBOLES Familiares: Assessing Risk of Breast Cancer through Outreach to Latinas with Education and Support GRAVES, KRISTI GEORGETOWN UNIVERSITY DC $324,001
Ovarian Cancer 2018 NCI 5R01CA181808-05 Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis RICHARDS, JOANNE BAYLOR COLLEGE OF MEDICINE TX $336,565
Ovarian Cancer 2018 NCI 5R01CA142746-09 Enzyme-instructed self-assembly for molecular anticancer nanomedicines XU, BING BRANDEIS UNIVERSITY MA $368,145
Ovarian Cancer 2018 NCI 5P50CA136393-09 7019 Biospecimens and Patient Registry KEENEY, GARY MAYO CLINIC ROCHESTER MN $129,460
Ovarian Cancer 2018 NCI 5P50CA136393-09 7020 Core C - Biostatistics Core OBERG, ANN MAYO CLINIC ROCHESTER MN $160,946
Ovarian Cancer 2018 NCI 5P50CA136393-09 7021 Core D - Animal Models Core HALUSKA, PAUL MAYO CLINIC ROCHESTER MN $148,438
Ovarian Cancer 2018 NCI 5P50CA136393-09 7022 Administrative Core KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $577,791
Ovarian Cancer 2018 NCI 5P50CA136393-09 7023 Project 1 - PARP Project KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $188,026
Ovarian Cancer 2018 NCI 5P50CA136393-09 7024 Project 6 - PKC Iota FIELDS, ALAN MAYO CLINIC ROCHESTER MN $285,250
Ovarian Cancer 2018 NCI 5P50CA136393-09 7025 Project 7 - Metformin LENGYEL, ERNST MAYO CLINIC ROCHESTER MN $354,079
Ovarian Cancer 2018 NCI 5P50CA136393-09 7026 Project 8 - TH17 Dendritic Cell Vaccine KNUTSON, KEITH MAYO CLINIC ROCHESTER MN $306,610
Ovarian Cancer 2018 NCI 5P50CA136393-09 7027 Developmental Reserach Pilot Projects CLIBY, WILLIAM MAYO CLINIC ROCHESTER MN $99,600
Ovarian Cancer 2018 NCI 5P50CA136393-09 7028 Career Development GOODE, ELLEN MAYO CLINIC ROCHESTER MN $49,800
Ovarian Cancer 2018 NCI 5R01CA188025-05 Iron addiction and the biology of ovarian cancer TORTI, SUZY UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $334,287
Ovarian Cancer 2018 NCI 1F30CA221004-01A1 Mechanisms of B-Myb oncogenicity in ovarian cancer INESS, AUDRA VIRGINIA COMMONWEALTH UNIVERSITY VA $34,856
Ovarian Cancer 2018 NCI 5U54CA163066-08 6613 Roles of proinflammatory chemokines linking obesity and ovarian cancer WHALEN, MARGARET TENNESSEE STATE UNIVERSITY TN $17,302
Ovarian Cancer 2018 NCI 1R43CA221464-01A1 Novel peptide drug conjugates for the treatment of triple-negative breast cancers: Direct anti-tumor activity and immuno-oncology preclinical studies. LAMHARZI, NAJIB ONCOTHERAPY SOLUTIONS, LLC WA $300,000
Ovarian Cancer 2018 NCI 5R01CA157664-09 Initiation and Evolution of the Ovarian Cancer Microenvironment CONEJO-GARCIA, JOSE H. LEE MOFFITT CANCER CTR & RES INST FL $408,500
Ovarian Cancer 2018 NCI 5P30CA047904-30 6388 Cancer Epidemiology and Prevention Program (Project-005) YUAN, JIAN-MIN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $35,797
Ovarian Cancer 2018 NCI 5P30CA047904-30 6390 Breast and Ovarian Cancer Program (Project-007) LEE, ADRIAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $34,500
Ovarian Cancer 2018 NCI 5P50CA116201-13 8257 01 Project 1: Cancer risks for mutations in breast cancer predisposition genes COUCH, FERGUS MAYO CLINIC ROCHESTER MN $508,510
Ovarian Cancer 2018 NCI 5R03CA208494-02 Development of Cell-based Functional Tests for Rare Germline ATM Gene Variants in Hereditary Ovarian Cancer Families TAINSKY, MICHAEL WAYNE STATE UNIVERSITY MI $77,000
Ovarian Cancer 2018 NCI 5U24CA210954-03 iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC ZHANG, BING BAYLOR COLLEGE OF MEDICINE TX $973,045
Ovarian Cancer 2018 NCI 5P01CA190174-04 7470 Adminstrative Core SPRIGGS, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $104,237
Ovarian Cancer 2018 NCI 5P01CA190174-04 7471 Biostatistics Core IASONOS, ALEXIA SLOAN-KETTERING INST CAN RESEARCH NY $81,105
Ovarian Cancer 2018 NCI 5P01CA190174-04 7472 Pathology Core DELAIR, DEBORAH SLOAN-KETTERING INST CAN RESEARCH NY $104,236
Ovarian Cancer 2018 NCI 5P01CA190174-04 7473 MUC16 Antibody Based Strategies for Imaging and Therapy SPRIGGS, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $729,636
Ovarian Cancer 2018 NCI 5P01CA190174-04 7474 Personalized Immunotherapy of Patients with Ovarian Cancer SABBATINI, PAUL SLOAN-KETTERING INST CAN RESEARCH NY $625,397
Ovarian Cancer 2018 NCI 5P01CA190174-04 7476 Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain RAVETCH, JEFFREY SLOAN-KETTERING INST CAN RESEARCH NY $389,221
Ovarian Cancer 2018 NCI 5U01CA202144-04 Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics ALTER, ORLY UNIVERSITY OF UTAH UT $741,952
Ovarian Cancer 2018 NCI 5U24CA210955-03 PNNL Proteome Characterization Center LIU, TAO BATTELLE PACIFIC NORTHWEST LABORATORIES WA $1,063,923
Ovarian Cancer 2018 NCI 5R01CA207456-03 Epidemiology and biology of lncRNAs in ovarian cancer SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $871,042
Ovarian Cancer 2018 NCI 5F31CA192891-05 Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer PRICE, JESSICA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $49,524
Ovarian Cancer 2018 NIGMS 5SC2GM122686-02 Targeted Promoter Demethylation in Ovarian Cancer Cells SUNG, CHANG TEXAS A&M UNIVERSITY-KINGSVILLE TX $137,999
Ovarian Cancer 2018 NCI 5U54CA163069-08 6965 Roles of proinflammatory chemokines linking obesity and ovarian cancer SON, DEOK-SOO MEHARRY MEDICAL COLLEGE TN $77,861
Ovarian Cancer 2018 NCI 5U54CA163072-09 6543 Roles of proinflammatory chemokines linking obesity and ovarian cancer BEEGHLY-FADIEL, ALICIA VANDERBILT UNIVERSITY MEDICAL CENTER TN $18,424
Ovarian Cancer 2018 NCI 5R01CA188943-04 Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors HILDEBRANDT, MICHELLE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $1,008,680
Ovarian Cancer 2018 NCI 5K08CA211362-03 Defining the formation and function of carcinoma-associated mesenchymal stem cells in the ovarian cancer microenvironment COFFMAN, LAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $166,050
Ovarian Cancer 2018 NCI 5R21CA210210-02 Targeting Cyclin E in Ovarian Cancer with Histone Deacetylase Inhibitors KHABELE, DINEO UNIVERSITY OF KANSAS MEDICAL CENTER KS $202,078
Ovarian Cancer 2018 NIGMS 5R01GM088055-19 Expanding Roles of E2 and E3 Enzymes in Ubiquitin Transfer KLEVIT, RACHEL UNIVERSITY OF WASHINGTON WA $563,419
Ovarian Cancer 2018 NCI 5UM1CA182910-06 Shanghai Womens Health Study ZHENG, WEI VANDERBILT UNIVERSITY MEDICAL CENTER TN $1,268,648
Ovarian Cancer 2018 NCI 1R43CA224579-01A1 Sprayable, Prompt Color Changing Dye to Delineate Ovarian Cancer During Surgery GRAY, BRIAN MOLECULAR TARGETING TECHNOLOGIES, INC. PA $229,603
Ovarian Cancer 2018 NCI 1R43CA224450-01A1 Preclinical Evaluation of VAX014 in Combination with Immune Checkpoint Inhibitors GIACALONE, MATTHEW VAXIION THERAPEUTICS, INC. CA $232,276
Ovarian Cancer 2018 NCI 5U01CA217842-02 Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer MILLS, GORDON UNIVERSITY OF TX MD ANDERSON CAN CTR TX $739,552
Ovarian Cancer 2018 NCI 5P01CA087969-19 8092 Core A: Biospecimen and High-Dimensional Data Management Core TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $629,241
Ovarian Cancer 2018 NCI 5P01CA087969-19 8096 Project 3: Ovarian Cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $326,903
Ovarian Cancer 2018 NCI 5P01CA087969-19 8097 Project 4: Statistical Innovations ROSNER, BERNARD BRIGHAM AND WOMEN'S HOSPITAL MA $167,985
Ovarian Cancer 2018 NCI 5R01CA181663-03 Mechanisms of radioresistance and strategies for radiosensitization in OCCC PENG, GUANG UNIVERSITY OF TX MD ANDERSON CAN CTR TX $368,805
Ovarian Cancer 2018 NCI 5R01CA214799-02 Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers JOHNSON, NEIL RESEARCH INST OF FOX CHASE CAN CTR PA $418,613
Ovarian Cancer 2018 NCI 5R44CA192569-03 Tumor-Specific Fluorescent Cocktail Enables Image-Guided Cytoreductive Surgery KULARATNE, SUMITH ON TARGET LABORATORIES, LLC IL $549,126
Ovarian Cancer 2018 NCI 5R01CA220468-02 Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery JOHNSON, JEREMIAH MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $509,485
Ovarian Cancer 2018 NCI 5R01CA207365-02 Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers REBBECK, TIMOTHY DANA-FARBER CANCER INST MA $642,340
Ovarian Cancer 2018 NCI 5R03CA216127-02 A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery YANG, YANG YALE UNIVERSITY CT $83,750
Ovarian Cancer 2018 NCI 5U54CA163071-07 5955 Adrenergic modulation of ovarian cancer progression and chemoresistance ARMAIZ-PENA, GUILLERMO PONCE SCHOOL OF MEDICINE PR $77,733
Ovarian Cancer 2018 NCI 5P50CA217685-02 5104 Administrative Core BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $165,684
Ovarian Cancer 2018 NCI 5P50CA217685-02 5105 Core 1: Pathology Core BROADDUS, RUSSELL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $231,014
Ovarian Cancer 2018 NCI 5P50CA217685-02 5106 Core 2: Bioinformatics and Biostatistics Core BAGGERLY, KEITH UNIVERSITY OF TX MD ANDERSON CAN CTR TX $176,085
Ovarian Cancer 2018 NCI 5P50CA217685-02 5107 Project 1: High Grade Cancers: Capitalizing on PARPness in Ovarian Carcinoma MILLS, GORDON UNIVERSITY OF TX MD ANDERSON CAN CTR TX $370,022
Ovarian Cancer 2018 NCI 5P50CA217685-02 5109 Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer COLEMAN, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $370,464
Ovarian Cancer 2018 NCI 5P50CA217685-02 5110 Project 4: SIK2 PROVIDES A NOVEL TARGET FOR OVARIAN CANCER THERAPY IN COMBINATION WITH PACLITAXEL AND INHIBITORS OF PARP BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $340,355
Ovarian Cancer 2018 NCI 5P50CA217685-02 5111 Developmental Research Program SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $80,000
Ovarian Cancer 2018 NCI 5P50CA217685-02 5112 Career Enhancement Program SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $80,000
Ovarian Cancer 2018 NCI 1P50CA228991-01 8871 Admin Core SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $189,072
Ovarian Cancer 2018 NCI 1P50CA228991-01 8872 Biorepository/Pathology Core FADER, AMANDA JOHNS HOPKINS UNIVERSITY MD $314,958
Ovarian Cancer 2018 NCI 1P50CA228991-01 8873 Biostatistics Core HUANG, PENG JOHNS HOPKINS UNIVERSITY MD $159,210
Ovarian Cancer 2018 NCI 1P50CA228991-01 8874 "Applying PapGene test for early ovarian cancer detection" PAPADOPOULOS, NICKOLAS JOHNS HOPKINS UNIVERSITY MD $501,816
Ovarian Cancer 2018 NCI 1P50CA228991-01 8875 "Optimizing synthetic lethality in high-grade serous ovarian cancer" SIMPKINS, FIONA JOHNS HOPKINS UNIVERSITY MD $374,652
Ovarian Cancer 2018 NCI 1P50CA228991-01 8876 Overcoming platinum resistance in ovarian cancer through BET inhibition. ZHANG, RUGANG JOHNS HOPKINS UNIVERSITY MD $367,780
Ovarian Cancer 2018 NCI 1P50CA228991-01 8877 "Exploring the potential of SYK inhibitors to sensitize ovarian cancer to the anti-tumor effects of paclitaxel" SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $345,550
Ovarian Cancer 2018 NCI 1P50CA228991-01 8878 Developmental Research Program DRAPKIN, RONNY JOHNS HOPKINS UNIVERSITY MD $111,875
Ovarian Cancer 2018 NCI 1P50CA228991-01 8879 Career Enhancement Program BURGER, ROBERT JOHNS HOPKINS UNIVERSITY MD $127,624
Ovarian Cancer 2018 NIMHD 5U54MD007600-32 5317 Upstream Regulation and Downstream effectors of c-MYC in Ovarian Cancer VIVAS-MEJIA, PABLO UNIVERSITY OF PUERTO RICO MED SCIENCES PR $340,378
Ovarian Cancer 2018 NCI 5U54CA163068-07 5836 Adrenergic modulation of ovarian cancer progression and chemoresistance MONTEIRO, ALVARO H. LEE MOFFITT CANCER CTR & RES INST FL $84,062
Ovarian Cancer 2018 NCI 1R21CA229044-01 Novel platform linking cancer-specific glycosylation with cell signaling outcomes ABBOTT, KAREN UNIV OF ARKANSAS FOR MED SCIS AR $225,250
Ovarian Cancer 2018 NHLBI 3R01HL132251-02S1 The Roles and Regulation of BRCA1 in Hematopoiesis ROSS, THEODORA UT SOUTHWESTERN MEDICAL CENTER TX $124,170
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer